Arrowhead Pharmaceuticals Cash Conversion Cycle 2011-2026 | ARWR

Annual Cash Conversion Cycle Arrowhead Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	8.75	14.7	3.13	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
14.7	3.13	8.84

Quarterly Cash Conversion Cycle Arrowhead Pharmaceuticals

2025-Q4	2025-Q3	2025-Q2	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
38.9	-	20	-	-	-	-	-	-	206	34.2	33.4	-	1.85	0.44	17.3	-	10.9	26.8	21.1	10.1	2.82	4.69	3.11	1.39	1.41	5.93	4.6	2.65	41.1	33.5	-109	0.71	-108	-97.3	-169	128	-98.5	-186	-120	-44.7	-129	4.1	-90.2	-30.8	-95.9	-25.9	117	135	90.2	154	-11.5	-7.75	-30.6	-41.9	-44.6	-48.4	-149	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
206	-186	-9.91

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Akebia Therapeutics AKBA	42	$ 1.35	-2.17 %	$ 347 M	USA
Alnylam Pharmaceuticals ALNY	46.6	$ 330.71	3.72 %	$ 43.3 B	USA
Altimmune ALT	7.85 K	$ 3.47	3.89 %	$ 306 M	USA
Amgen AMGN	217	$ 346.45	-0.43 %	$ 186 B	USA
I-Mab IMAB	-1.97 K	-	-	$ 866 M	China
Amneal Pharmaceuticals AMRX	117	$ 12.37	-0.92 %	$ 3.88 B	USA
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Anika Therapeutics ANIK	270	$ 15.0	1.32 %	$ 220 M	USA
ANI Pharmaceuticals ANIP	235	$ 76.34	2.87 %	$ 1.47 B	USA
Aptorum Group Limited APM	-400	$ 0.92	-1.11 %	$ 5.02 M	China
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Aquestive Therapeutics AQST	-172	$ 4.15	0.48 %	$ 444 M	USA
Arcturus Therapeutics Holdings ARCT	21.2	$ 8.43	4.98 %	$ 231 M	Israel
Ardelyx ARDX	885	$ 6.08	2.27 %	$ 1.47 B	USA
Acorda Therapeutics ACOR	117	-	-24.86 %	$ 820 K	USA
Arcutis Biotherapeutics ARQT	158	$ 23.93	1.27 %	$ 3.04 B	USA
Arvinas ARVN	4.66	$ 11.11	2.4 %	$ 788 M	USA
Advaxis ADXS	-143 K	-	-9.65 %	$ 45.9 M	USA
Assembly Biosciences ASMB	25.1	$ 30.01	3.43 %	$ 336 M	USA
Aeterna Zentaris AEZS	-34.3 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	-1.92	-	1.93 %	$ 17.4 M	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Atossa Therapeutics ATOS	-2.25 K	$ 5.21	-2.89 %	$ 44.9 M	USA
Atara Biotherapeutics ATRA	4.13	$ 5.03	0.7 %	$ 63.1 M	USA
Aurinia Pharmaceuticals AUPH	612	$ 16.04	2.75 %	$ 2.16 B	Canada
Autolus Therapeutics plc AUTL	119	$ 1.42	0.35 %	$ 378 M	Britain
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA